Vanguard Group’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Sell |
|
|||||
|
2025
Q1 | $670K | Sell |
|
|||||
|
2024
Q4 | $1.47M | Sell |
|
|||||
|
2024
Q3 | $1.84M | Buy |
|
|||||
|
2024
Q2 | $5.18M | Buy |
|
|||||
|
2024
Q1 | $7.86M | Buy |
|
|||||
|
2023
Q4 | $629K | Buy |
|
|||||
|
2023
Q3 | $709K | Sell |
|
|||||
|
2023
Q2 | $1.63M | Buy |
|
|||||
|
2023
Q1 | $866K | Buy |
|
|||||
|
2022
Q4 | $317K | Buy |
|
|||||
|
2022
Q3 | $376K | Sell |
|
|||||
|
2022
Q2 | $561K | Buy |
|
|||||
|
2022
Q1 | $948K | Sell |
|
|||||
|
2021
Q4 | $2.29M | Sell |
|
|||||
|
2021
Q3 | $5.11M | Buy |
|
|||||
|
2021
Q2 | $814K | Buy |
|